Gastrodin, a Promising Natural Small Molecule for the Treatment of Central Nervous System Disorders, and Its Recent Progress in Synthesis, Pharmacology and Pharmacokinetics
International Journal of Molecular Sciences · 02.09.2024 · 25 (17) · 9540
DOI: 10.3390/ijms25179540 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.09.2024. Verfasst von Yanan Dai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China. Hauptthemen laut MEDLINE: Benzyl Alcohols, Glucosides, Central Nervous System Diseases. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the CAMS Innovation Fund for Medical Science, National Natural Science Foundation of China, Beijing Science and Technology Programme.
Abstract (Originalsprache)
Gastrodia elata Blume is a traditional medicinal and food homology substance that has been used for thousands of years, is mainly distributed in China and other Asian countries, and has always been distinguished as a superior class of herbs. Gastrodin is the main active ingredient of G. elata Blume and has attracted increasing attention because of its extensive pharmacological activities. In addition to extraction and isolation from the original plant, gastrodin can also be obtained via chemical synthesis and biosynthesis. Gastrodin has significant pharmacological effects on the central nervous system, such as sedation and improvement of sleep. It can also improve epilepsy, neurodegenerative diseases, emotional disorders and cognitive impairment to a certain extent. Gastrodin is rapidly absorbed and widely distributed in the body and can also penetrate the blood–brain barrier. In brief, gastrodin is a promising natural small molecule with significant potential in the treatment of brain diseases. In this review, we summarised studies on the synthesis, pharmacological effects and pharmacokinetic characteristics of gastrodin, with emphasis on its effects on central nervous system disorders and the possible mechanisms, in order to find potential therapeutic applications and provide favourable information for the research and development of gastodin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China.
ORCID-Profile: Zhihong Yang
Förderung
- the CAMS Innovation Fund for Medical Science
- National Natural Science Foundation of China
- Beijing Science and Technology Programme
- CAMS Innovation Fund for Medical Science (CIFMS)
Zitieren
APA
Dai, Y., Ban, W., & Yang, Z. (2024). Gastrodin, a Promising Natural Small Molecule for the Treatment of Central Nervous System Disorders, and Its Recent Progress in Synthesis, Pharmacology and Pharmacokinetics. International Journal of Molecular Sciences, 25(17), 9540. https://doi.org/10.3390/ijms25179540
Vancouver
Dai Y, Ban W, Yang Z. Gastrodin, a Promising Natural Small Molecule for the Treatment of Central Nervous System Disorders, and Its Recent Progress in Synthesis, Pharmacology and Pharmacokinetics. International Journal of Molecular Sciences. 2024;25(17):9540. doi:10.3390/ijms25179540
BibTeX
@article{Dai2024,
author = {Dai, Yanan and Ban, Weikang and Yang, Zhihong},
title = {Gastrodin, a Promising Natural Small Molecule for the Treatment of Central Nervous System Disorders, and Its Recent Progress in Synthesis, Pharmacology and Pharmacokinetics},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {17},
pages = {9540},
doi = {10.3390/ijms25179540}
}
EUVIMED